New strategies for targeting kinase networks in cancer
Open Access
- 27 August 2021
- journal article
- review article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (4) , 101128
Abstract
No abstract availableKeywords
Funding Information
- Universidade de São Paulo (18.5.245.86.7)
- National Institutes of Health
This publication has 89 references indexed in Scilit:
- Structure, Regulation, Signaling, and Targeting of Abl Kinases in CancerGenes & Cancer, 2012
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast CancerCell, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- ABC-SysBio—approximate Bayesian computation in Python with GPU supportBioinformatics, 2010
- Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare WorseClinical Cancer Research, 2010
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KITJournal of Clinical Oncology, 2008
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLOS Medicine, 2005
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000